Advertisement
UK markets closed
  • NIKKEI 225

    39,239.52
    +5.81 (+0.01%)
     
  • HANG SENG

    16,790.80
    +156.06 (+0.94%)
     
  • CRUDE OIL

    78.52
    +0.94 (+1.21%)
     
  • GOLD FUTURES

    2,039.40
    +0.50 (+0.02%)
     
  • DOW

    38,972.41
    -96.82 (-0.25%)
     
  • Bitcoin GBP

    44,868.51
    +1,875.74 (+4.36%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    16,035.30
    +59.05 (+0.37%)
     
  • UK FTSE All Share

    4,191.43
    +0.63 (+0.02%)
     

Biosensors Market Poised to Reach $49.3 Billion Globally by 2030, with Substantial Growth in Wearable and Non-Wearable Segments

Company Logo
Company Logo

Biosensors Market

Biosensors Market
Biosensors Market

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Biosensors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The comprehensive analysis and insightful data within the latest strategic business report on the global Biosensors market highlights a significant growth trajectory for the industry, with forecasts indicating a market expansion from US$28.5 billion in 2022 to an estimated US$49.3 billion by 2030. A robust compound annual growth rate (CAGR) of 7.1% is anticipated for the review period of 2022-2030.

This extensive report brings to light the segment-wise growth potential with a special focus on non-wearable biosensors, which are poised to exhibit a 6.5% CAGR, reaching a significant value of US$25.9 billion by the end of the forecast period. The wearable biosensors segment is not far behind, as it is estimated to flourish at a faster CAGR of 7.8% through 2030.

In the latest findings, the United States Biosensors market stands out, valued at US$11.2 billion in 2022, set to maintain a sturdy incremental growth path. Meanwhile, China is rapidly emerging as a formidable market, projected to attain a robust 8.6% CAGR within the tenure reaching up to 2030. Offering additional insights, the report covers the Japanese and Canadian markets, each projected to ascend at 5.9% and 6.7% CAGR, respectively, throughout the span of 2022-2030. Germany's market is also set to bolster at a CAGR of approximately 6.4%.

Competitive Landscape and Market Dynamics

The research canvasses an array of influential competitors within the Biosensors market, featuring 119 notable entities. Among them are key industry titans such as:

  • Abbott Laboratories

  • Bio-Rad Laboratories, Inc.

  • Cytiva

  • Dexcom, Inc.

  • Masimo Corporation

  • Medtronic Plc

  • Nova Biomedical

  • Siemens Medical Solutions USA, Inc.

  • Thermo Fisher Scientific Inc.

  • WaveForm Technologies, Inc.

The overarching economic outlook remains promising, and although challenged by an array of global issues, business sentiment continues to take a turn for the positive, buoyed by technology advancements and resilient market strategies. As geopolitical uncertainties persist and inflationary pressures impact economies, the landscape becomes a complex mix of hurdles to be navigated by corporations and investors alike.

Key Attributes:

Report Attribute

Details

No. of Pages

504

Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$28.5 Billion

Forecasted Market Value (USD) by 2030

$49.3 Billion

Compound Annual Growth Rate

7.1%

Regions Covered

Global

For more information about this report visit https://www.researchandmarkets.com/r/le297x

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900